CrestOptics and Tomocube have unveiled the HT-X1™ Plus, a multimodal imaging platform designed to meet the evolving needs of contract research laboratories. By integrating label-free holotomography with spinning disk confocal fluorescence microscopy, this platform enables comprehensive, non-invasive analysis of molecular and phenotypic data.
Benefits for Contract Testing Laboratories:
- Enhanced Service Offerings: Expand capabilities with dual-modality imaging.
- Non-Invasive Techniques: Eliminate the need for labeling, preserving sample integrity.
- Precision Data Alignment: Deliver highly accurate datasets to clients.
- Comprehensive Insights: Study molecular distributions and phenotypic data in tandem.
- Competitive Advantage: Position your lab as a leader in advanced biophysical research.
The HT-X1™ Plus delivers unparalleled imaging capabilities, empowering contract labs to push the boundaries of biophysical and molecular research.
This article is an AI generated summary of a published press release provided by CrestOptics and Tomocube
